Abstract
Corneal wound healing is a complex procedure that involves apoptosis, migration, proliferation, and differentiation of cells. Several growth factors and cytokines are necessary to perform this process. Due to the avascular nature of the cornea, these growth factors proceed from sources such as tears, inflammatory cells, epithelium, or stroma. Depending on the extent and type of injury, the healing response can produce corneal scarring, with loss of corneal transparency leading to visual impairment.
In this chapter, we are going to describe the different cytokines and growth factors involved in the healing procedure, as the different phases during the recovery of each corneal layer.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Dawson D, Ubels JL, Edelhauser HF. Cornea and sclera. In: Levin LA, Alm A, Nilsson SFE, Ver Hoeve J, Wu S, editors. Adler’s physiology of the eye. Edinburgh: Saunders; 2011. p. 71–130.
Agrawal VB, Tsai RJF. Corneal epithelial wound healing. Indian J Ophthalmol. 2003;51:5–1.
Nishida T, Saika S, Morishige N. Cornea and sclera: anatomy and physiology. In: Krachmer J, Mannis M, Holland E, editors. Cornea. St. Louis: Mosby; 2011. p. 1–22.
Sotozono C, He J, Matsimoto Y, Kita M, Imanishi J, Kinoshita S. Cytokine expression in the alkali-burned cornea. Curr Eye Res. 1997;16:670–6.
Ashby BD, Garrett Q, Willcox MDP. Corneal injuries and wound healing – review of processes and therapies. Austin J Clin Ophthalmol. 2014;1(4):1017.
Liu C-Y, Kao WW-Y. Corneal epithelial wound healing. Prog Mol Biol Transl Sci. 2015;5:1–11.
Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res. 2015;49:17. https://doi.org/10.1016/j.preteyeres.2015.07.002.
Sugioka K, Mishima H, Kodama A, Itahashi M, Fukuda M, Shimomura Y. Regulatory mechanism of collagen degradation by keratocytes and corneal inflammation: the role of Urokinase-type plasminogen activator. Cornea. 2016;35(Suppl):S59–64.
Klenkler B, Sheardown H, Jones L. Growth factors in the tear film: role in tissue maintenance, wound healing, and ocular pathology. Ocul Surf. 2007;5(3):228–39.
Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000;19(1):113–29.
Miyagi H, Thomasy SM, Russell P, Murphy CJ. The role of hepatocyte growth factor in corneal wound healing. Exp Eye Res. 2018;166:49–55.
Omoto M, Suri K, Amouzegar A, Li M, Katikireddy KR, Mittal SK, et al. Hepatocyte growth factor suppresses inflammation and promotes epithelium repair in corneal injury. Mol Ther. 2017;25(8):1–8.
Lambiase A, Sacchetti M, Bonini S. Nerve growth factor therapy for corneal disease. Curr Opin Ophthalmol. 2012;23:296–302.
Saghizadeh M, Kramerov AA, Svendsen CN, Ljubimov AV. Concise review: stem cells for corneal wound healing. Stem Cells. 2017;35:2105–14.
Dua HS, Gomes JAP, Singh A. Corneal epithelial wound healing. Br J Ophthalmol. 1994;78:401–8.
Torricelli A, Santhanam A, Wu J, Singh V, Wilson S. The corneal fibrosis response to epithelial-stromal injury. Exp Eye Res. 2016;142:110–8.
Bukowiecki A, Hos D, Cursiefen C, Eming SA. Wound-healing studies in cornea and skin: parallels, differences and opportunities. Int J Mol Sci. 2017;18:1–24.
Wilson SE. Corneal myofibroblast biology and pathobiology: generation, persistence and transparency. Exp Eye Res. 2012;99(1):78–88. https://doi.org/10.1016/j.exer.2012.03.018.
Marino GK, Santhiago MR, Torricelli AAM, Santhanam A, Wilson SE. Corneal molecular and cellular biology for the refractive surgeon: the critical role of the epithelial basement membrane. J Refract Surg. 2016;32(2):118–25.
Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology. 2000;107:1347–52.
Cellini M, Bendo E, Bravetti GO, Campos EC. The use of nerve growth factor in surgical wound healing of the cornea. Ophthalmic Res. 2006;38:177–81.
Lambiase A, Bonini S, Aloe L, et al. Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Arch Ophthalmol. 2000;118:1446–9.
Nishida T, Chikama T, Morishige N, Yanai R, Yamada N, Saito J. Persistent epithelial defects due to neurotrophic keratopathy treated with a substance P- derived peptide and insulin-like growth factor 1. Jpn J Ophthalmol. 2007;51:442–7.
Yamada N, Matsuda R, Morishige N, Yanai R, Chikama T-i, Nishida T, Ishimitsu T, Kamiya A. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment or persistent corneal epithelial defects associated with neurotrophic keratopathy. Br J Ophthalmol. 2008;92:896–900.
Holland S, Morck D, Schultz C. Treatment of corneal defects with delayed re-epithelization with a medical device/drug delivery system for epidermal growth factor. Clin Exp Ophthalmol. 2012;40:1–6. https://doi.org/10.1111/j.1442-9071.2012.02795.x.
Alió JL, Arnalich-Montiel F, Rodriguez AE. The role of “eye platelet rich plasma” (E-Prp) for wound healing in ophthalmology. Curr Pharm Biotechnol. 2012;13:1257–65.
Alio JL, Abad M, Artola A, Rodriguez-Prats JL, Pastor S, Ruiz-Colecha J. Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers. Ophthalmology. 2007;114(7):1286–93.
Waring GO, Bourne WM, Edelhauser HF, Kenyon KR. The corneal endothelium. Normal and pathologic structure and function. Ophthalmology. 1982;89(6):531–90.
Edelhauser HF. The resiliency of the corneal endothelium to refractive and intraocular surgery. Cornea. 2000;19(3):263–73.
Joyce NC. Proliferative capacity of the corneal endothelium. Prog Retin Eye Res. 2003;22(3):359–89.
Watsky MA, McDermott ML, Edelhauser HF. In vitro corneal endothelial permeability in rabbit and human: the effects of age, cataract surgery and diabetes. Exp Eye Res. 1989;49(5):751–67.
Senoo T, Joyce NC. Cell cycle kinetics in corneal endothelium from old and young donors. Invest Ophthalmol Vis Sci. 2000;41(3):660–7.
Yoshida K, Kase S, Nakayama K, Nagahama H, Harada T, Ikeda H, et al. Involvement of p27KIP1 in the proliferation of the developing corneal endothelium. Invest Ophthalmol Vis Sci. 2004;45(7):2163–7.
Joyce NC, Zhu CC, Harris DL. Relationship among oxidative stress, DNA damage, and proliferative capacity in human corneal endothelium. Invest Ophthalmol Vis Sci. 2009;50(5):2116–22.
Van den Bogerd B, Dhubhghaill SN, Koppen C, Tassignon M-J, Zakaria N. A review of the evidence for in vivo corneal endothelial regeneration. Surv Ophthalmol. 2018;63:149–65.
Dirisamer M, Ham L, Dapena I, van Dijk K, Melles GRJ. Descemet membrane endothelial transfer: “free-floating” donor descemet implantation as a potential alternative to “keratoplasty”. Cornea. 2012;31(2):194–7.
Okumura N, Ueno M, Koizumi N, Sakamoto Y, Hirata K, Hamuro J, et al. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest Ophthalmol Vis Sci. 2009;50(8):3680–7.
Okumura N, Okazaki Y, Inoue R, Kakutani K, Nakano S, Kinoshita S, et al. Effect of the Rho-associated kinase inhibitor eye drop (Ripasudil) on corneal endothelial wound healing. Invest Ophthalmol Vis Sci. 2016;57(3):1284–92.
Okumura N, Sakamoto Y, Fujii K, Kitano J, Nakano S, Tsujimoto Y, et al. Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction. Sci Rep. 2016;6(1):26113.
Okumura N, Inoue R, Okazaki Y, Nakano S, Nakagawa H, Kinoshita S, et al. Effect of the Rho kinase inhibitor Y-27632 on corneal endothelial wound healing. Investig Opthalmology Vis Sci. 2015;56(10):6067.
Moloney G, Petsoglou C, Ball M, Kerdraon Y, Höllhumer R, Spiteri N, et al. Descemetorhexis without grafting for fuchs endothelial dystrophy-supplementation with topical Ripasudil. Cornea. 2017;36(6):642–8.
Koizumi N, Okumura N, Ueno M, Nakagawa H, Hamuro J, Kinoshita S. Rho-associated kinase inhibitor eye drop treatment as a possible medical treatment for Fuchs corneal dystrophy. Cornea. 2013;32(8):1167–70.
Lam FC, Baydoun L, Dirisamer M, Lie J, Dapena I, Melles GRJ. Hemi-Descemet membrane endothelial keratoplasty transplantation: a potential method for increasing the pool of endothelial graft tissue. JAMA Ophthalmol. 2014;132(12):1469–73.
Lam FC, Bruinsma M, Melles GRJ. Descemet membrane endothelial transfer. Curr Opin Ophthalmol. 2014;25(4):353–7.
Katikireddy KR, Schmedt T, Price MO, Price FW, Jurkunas UV. Existence of neural crest-derived progenitor cells in Normal and Fuchs endothelial dystrophy corneal endothelium. Am J Pathol. 2016;186(10):2736–50.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Financial Disclosure
Financial Disclosure
None of the authors have any financial disclosure
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Vargas, V., Arnalich-Montiel, F., Alió del Barrio, J.L. (2019). Corneal Healing. In: Alió, J., Alió del Barrio, J., Arnalich-Montiel, F. (eds) Corneal Regeneration . Essentials in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-030-01304-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-01304-2_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-01303-5
Online ISBN: 978-3-030-01304-2
eBook Packages: MedicineMedicine (R0)